Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.
Sattar NA, Ginsberg H, Ray K, Chapman MJ, Arca M, Averna M, Betteridge DJ, Bhatnagar D, Bilianou E, Carmena R, Ceška R, Corsini A, Erbel R, Flynn PD, Garcia-Moll X, Gumprecht J, Ishibashi S, Jambart S, Kastelein JJ, Maher V, da Silva PM, Masana L, Odawara M, Pedersen TR, Rotella CM, Salti I, Teramoto T, Tokgozoglu L, Toth PP, Valensi P, Vergès B. Sattar NA, et al. Among authors: gumprecht j. Atheroscler Suppl. 2014 Jun;15(1):1-15. doi: 10.1016/j.atherosclerosissup.2014.04.001. Atheroscler Suppl. 2014. PMID: 24840509 Free article. Review.
Importance of observational studies in clinical practice.
Ligthelm RJ, Borzì V, Gumprecht J, Kawamori R, Wenying Y, Valensi P. Ligthelm RJ, et al. Among authors: gumprecht j. Clin Ther. 2007 Jun;29(6 Pt 1):1284-92. doi: 10.1016/j.clinthera.2007.07.004. Clin Ther. 2007. PMID: 18036390 Review.
Importance of observational studies in clinical practice.
Ligthelm RJ, Borzì V, Gumprecht J, Kawamori R, Wenying Y, Valensi P. Ligthelm RJ, et al. Among authors: gumprecht j. Clin Ther. 2007;29 Spec No:1284-92. Clin Ther. 2007. PMID: 18046928 Review.
The IMPROVE study--a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts.
Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y; IMPROVE Study Group Expert Panel. Valensi P, et al. Among authors: gumprecht j. Int J Clin Pract. 2008 Nov;62(11):1809-19. doi: 10.1111/j.1742-1241.2008.01917.x. Epub 2008 Sep 22. Int J Clin Pract. 2008. PMID: 18811598 Clinical Trial.
Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y; IMPROVE Study Group Expert Panel. Valensi P, et al. Among authors: gumprecht j. Int J Clin Pract. 2009 Mar;63(3):522-31. doi: 10.1111/j.1742-1241.2009.02002.x. Epub 2009 Jan 27. Int J Clin Pract. 2009. PMID: 19187170 Clinical Trial.
Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational study.
Gumprecht J, Benroubi M, Borzi V, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y, Ligthelm R, Valensi P; IMPROVE Study Group Expert Panel. Gumprecht J, et al. Int J Clin Pract. 2009 Jun;63(6):966-72. doi: 10.1111/j.1742-1241.2009.02064.x. Int J Clin Pract. 2009. PMID: 19504715 Free PMC article. Clinical Trial.
Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P; IMPROVE Study Group Expert Panel. Wenying Y, et al. Among authors: gumprecht j. Curr Med Res Opin. 2009 Nov;25(11):2643-54. doi: 10.1185/03007990903276745. Curr Med Res Opin. 2009. PMID: 19751116
Predictors of postprandial blood glucose response to biphasic insulin analogue therapy.
Borzì V, Benroubi M, Gumprecht J, Kawamori R, Ligthelm R, Shaban J, Shah S, Shestakova M, Wenying Y, Valensi P; IMPROVE™ Study Expert Panel. Borzì V, et al. Among authors: gumprecht j. Prim Care Diabetes. 2013 Apr;7(1):63-7. doi: 10.1016/j.pcd.2012.09.002. Epub 2012 Nov 20. Prim Care Diabetes. 2013. PMID: 23182405
Predictors of achieving HbA(1c) <7% and no hypoglycaemia 6 months after initiation of biphasic insulin aspart 30 in patients with type 2 diabetes in the IMPROVE study.
Valensi P, Shaban J, Benroubi M, Kawamori R, Borzì V, Shah S, Wenying Y, Prusty V, Hansen JB, Gumprecht J; IMPROVE Study Expert Panel. Valensi P, et al. Among authors: gumprecht j. Curr Med Res Opin. 2013 Jun;29(6):601-9. doi: 10.1185/03007995.2013.786692. Epub 2013 Apr 12. Curr Med Res Opin. 2013. PMID: 23488447
188 results